• Immunic will host a virtual progressive multiple sclerosis R&D day Nov. 5, 2026, at 12:30 p.m. ET, focusing on unmet treatment needs.
• Guggenheim 3rd Annual Healthcare Innovation Conference participation in Boston, Nov. 9-11; fireside chat Nov. 9 at 1 p.m. ET.
• Stifel 2026 Healthcare Conference participation in New York, Nov. 10-12; fireside chat Nov. 11 at 2 p.m. ET.
• Management will hold one-on-one investor meetings in London Nov. 17-18 in connection with the Jefferies Global Healthcare Conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2425846_en) on November 02, 2026, and is solely responsible for the information contained therein.